Viking Therapeutics (VKTX) EPS (Weighted Average and Diluted) (2017 - 2025)
Historic EPS (Weighted Average and Diluted) for Viking Therapeutics (VKTX) over the last 8 years, with Q4 2025 value amounting to -$1.39.
- Viking Therapeutics' EPS (Weighted Average and Diluted) fell 33437.5% to -$1.39 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.19, marking a year-over-year decrease of 21900.0%. This contributed to the annual value of -$3.19 for FY2025, which is 21584.16% down from last year.
- Per Viking Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$1.39 for Q4 2025, which was down 33437.5% from -$0.81 recorded in Q3 2025.
- Viking Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.16 during Q4 2021, with a 5-year trough of -$1.39 in Q4 2025.
- In the last 5 years, Viking Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.23 in 2022 and averaged -$0.34.
- Per our database at Business Quant, Viking Therapeutics' EPS (Weighted Average and Diluted) surged by 1739.13% in 2023 and then plummeted by 33437.5% in 2025.
- Over the past 5 years, Viking Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.16 in 2021, then plummeted by 62.5% to -$0.26 in 2022, then increased by 3.85% to -$0.25 in 2023, then fell by 28.0% to -$0.32 in 2024, then plummeted by 334.37% to -$1.39 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$1.39 for Q4 2025, versus -$0.81 for Q3 2025 and -$0.58 for Q2 2025.